Clawback escalation to 79.8% for innovative hospital therapies
A threat to patient access and public health PhARMA Innovation Forum (PIF) expresses its deep concern regarding the official data released by EKAPY (National Central Health Procurement Authority) – with a delay of more than a year – to our member companies. Once again, the figures reveal a complete derailment of the public budget for…